<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">101238455</journal-id>
<journal-title>International Journal of Environmental Research and Public Health</journal-title>
<issn pub-type="ppub">1661-7827</issn>
<issn pub-type="epub">1660-4601</issn>
<publisher>
<publisher-name>Molecular Diversity Preservation International (MDPI)</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3390/ijerph6122934</article-id>
<article-id pub-id-type="publisher-id">ijerph-06-02934</article-id>
<article-categories>
<subj-group>
<subject>Article</subject></subj-group></article-categories>
<title-group>
<article-title>Chronic Stress and the Development of Early Atherosclerosis: Moderating Effect of Endothelial Dysfunction and Impaired Arterial Elasticity</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Chumaeva</surname><given-names>Nadja</given-names></name><xref ref-type="aff" rid="af1-ijerph-06-02934">1</xref><xref ref-type="aff" rid="af2-ijerph-06-02934">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>Hintsanen</surname><given-names>Mirka</given-names></name><xref ref-type="aff" rid="af1-ijerph-06-02934">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>Ravaja</surname><given-names>Niklas</given-names></name><xref ref-type="aff" rid="af3-ijerph-06-02934">3</xref></contrib>
<contrib contrib-type="author">
<name><surname>Juonala</surname><given-names>Markus</given-names></name><xref ref-type="aff" rid="af4-ijerph-06-02934">4</xref></contrib>
<contrib contrib-type="author">
<name><surname>Raitakari</surname><given-names>Olli T.</given-names></name><xref ref-type="aff" rid="af5-ijerph-06-02934">5</xref><xref ref-type="aff" rid="af6-ijerph-06-02934">6</xref></contrib>
<contrib contrib-type="author">
<name><surname>Keltikangas-Järvinen</surname><given-names>Liisa</given-names></name><xref ref-type="aff" rid="af1-ijerph-06-02934">1</xref><xref ref-type="corresp" rid="c1-ijerph-06-02934">*</xref></contrib></contrib-group>
<aff id="af1-ijerph-06-02934">
<label>1</label> Department of Psychology, University of Helsinki, P.O. Box 9, 00014 Helsinki, Finland; E-Mails: 
<email>nadezda.chumaeva@helsinki.fi</email> (N.C.); 
<email>mirka.hintsanen@helsinki.fi</email> (M.H.)</aff>
<aff id="af2-ijerph-06-02934">
<label>2</label> Division of Medical Problems of Cell Biology, Institute of Cell Biophysics, Institutional Street 3, Pushchino, Moscow region 142290, Russia</aff>
<aff id="af3-ijerph-06-02934">
<label>3</label> Center for Knowledge and Innovation Research, Helsinki School of Economics, P.O. Box 1210, 00101 Helsinki, Finland; E-Mail: 
<email>niklas.ravaja@hse.fi</email></aff>
<aff id="af4-ijerph-06-02934">
<label>4</label> Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Kiinanmyllynkatu 10, 20520 Turku, Finland; E-Mails: 
<email>markus.juonala@utu.fi</email></aff>
<aff id="af5-ijerph-06-02934">
<label>5</label> Department of Clinical Physiology, University of Turku, P.O. Box 52, 20521 Turku, Finland; E-Mail: 
<email>olli.raitakari@utu.fi</email></aff>
<aff id="af6-ijerph-06-02934">
<label>6</label> Department of Medicine, University of Turku and Turku University Hospital, P.O. Box 52, 20521 Turku, Finland</aff>
<author-notes>
<corresp id="c1-ijerph-06-02934">
<label>*</label> Author to whom correspondence should be addressed; E-mail: 
<email>liisa.keltikangas-jarvinen@helsinki.fi</email>; Tel.: +358-9-191 29500; Fax: +358-9-191 29521.</corresp></author-notes>
<pub-date pub-type="ppub">
<month>12</month>
<year>2009</year></pub-date>
<pub-date pub-type="epub">
<day>27</day>
<month>11</month>
<year>2009</year></pub-date>
<volume>6</volume>
<issue>12</issue>
<fpage>2934</fpage>
<lpage>2949</lpage>
<history>
<date date-type="received">
<day>15</day>
<month>9</month>
<year>2009</year></date>
<date date-type="accepted">
<day>20</day>
<month>11</month>
<year>2009</year></date></history>
<permissions>
<copyright-statement>© 2009 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland.</copyright-statement>
<copyright-year>2009</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<p>This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p></license></permissions>
<abstract>
<p>This study aims to explore the interactive effect of vital exhaustion (VE) and endothelial dysfunction on preclinical atherosclerosis, assessed by carotid intima-media thickness (IMT). Furthermore, interaction between VE and carotid elasticity is examined. Participants were 1,596 young healthy adults from the Cardiovascular Risk in Young Finns study. Endothelial dysfunction was measured by brachial flow-mediated dilatation (FMD), and carotid elasticity by carotid artery compliance (CAC). Significant interactions between FMD and VE, and between CAC and VE, for IMT were found in participants with the very lowest FMD and CAC. Thus, VE may be harmful if the endothelium is not working properly.</p></abstract>
<kwd-group>
<kwd>chronic stress</kwd>
<kwd>vital exhaustion</kwd>
<kwd>intima-media thickness</kwd>
<kwd>flow-mediated dilatation</kwd>
<kwd>carotid artery compliance</kwd>
<kwd>atherosclerosis</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<label>1.</label>
<title>Introduction</title>
<p>Atherosclerosis is a chronic progressive disease with a long preclinical phase. Risk factors such as age, smoking, blood pressure, hypercholesterolemia, hyperglycemia, diabetes, obesity, hypertension, infection/inflammation, and genetic factors are associated with the development of atherosclerosis, and are known to impair endothelial function [<xref ref-type="bibr" rid="b1-ijerph-06-02934">1</xref>], a key factor in the early atherogenic process [<xref ref-type="bibr" rid="b2-ijerph-06-02934">2</xref>]. Recent studies have shown that psychosocial factors may accelerate the development of carotid atherosclerosis [<xref ref-type="bibr" rid="b3-ijerph-06-02934">3</xref>].</p>
<p>Impaired endothelial function triggers the first step of atherosclerosis progression and manifests long before the establishment of atherosclerotic disease [<xref ref-type="bibr" rid="b2-ijerph-06-02934">2</xref>]. Non-invasive ultrasound measurement of brachial artery diameter changes due to reactive hyperemia-induced endothelial nitric oxide (NO) release is used as a method for evaluating endothelial function [<xref ref-type="bibr" rid="b4-ijerph-06-02934">4</xref>]. The change in diameter before and during hyperemia has been taken as an index of endothelial NO production and called flow-mediated dilatation (FMD) [<xref ref-type="bibr" rid="b4-ijerph-06-02934">4</xref>]. Reduced FMD has been shown to be related to the frequency and degree of coronary atherosclerosis [<xref ref-type="bibr" rid="b5-ijerph-06-02934">5</xref>]. Thus, FMD reflects the vascular endothelium status and may be used as a functional marker of atherosclerotic risk and as one of the endothelial health markers [<xref ref-type="bibr" rid="b6-ijerph-06-02934">6</xref>].</p>
<p>Carotid artery compliance (CAC) is widely used as an index of arterial elasticity [<xref ref-type="bibr" rid="b7-ijerph-06-02934">7</xref>]. Small artery compliance has been considered as an early marker for cardiovascular diseases [<xref ref-type="bibr" rid="b7-ijerph-06-02934">7</xref>], and it may be an additional indicator of early atherosclerosis [<xref ref-type="bibr" rid="b7-ijerph-06-02934">7</xref>,<xref ref-type="bibr" rid="b8-ijerph-06-02934">8</xref>].</p>
<p>Carotid intima-media thickness (IMT) has been shown to correlate to the severity of generalized atherosclerosis [<xref ref-type="bibr" rid="b9-ijerph-06-02934">9</xref>]. Increased carotid IMT is associated with coronary atherosclerosis [<xref ref-type="bibr" rid="b10-ijerph-06-02934">10</xref>] and with the standard cardiovascular risk factors [<xref ref-type="bibr" rid="b1-ijerph-06-02934">1</xref>].</p>
<p>Thus, carotid IMT, arterial compliance, and brachial FMD are important indexes of preclinical cardiovascular disease [<xref ref-type="bibr" rid="b7-ijerph-06-02934">7</xref>], and may serve as the markers of vascular health [<xref ref-type="bibr" rid="b11-ijerph-06-02934">11</xref>]. Individuals having impaired FMD and a reduced arterial compliance may be considered to have decreased vascular health and they are at an increased coronary risk [<xref ref-type="bibr" rid="b1-ijerph-06-02934">1</xref>,<xref ref-type="bibr" rid="b12-ijerph-06-02934">12</xref>]. The vascular health status may be suggested to influence the association between risk factors and atherosclerosis.</p>
<p>Chronic stress has been shown to be a risk factor for atherosclerosis development [<xref ref-type="bibr" rid="b13-ijerph-06-02934">13</xref>], and it has been found to contribute to endothelial dysfunction [<xref ref-type="bibr" rid="b14-ijerph-06-02934">14</xref>]. Vital exhaustion (VE) is determined as a psychological state which can be characterized by heightened irritability, unusual tiredness, a loss of physical and mental energy, and demoralized feelings [<xref ref-type="bibr" rid="b15-ijerph-06-02934">15</xref>]. It has been considered as an indicator of chronic mental stress [<xref ref-type="bibr" rid="b16-ijerph-06-02934">16</xref>] and reflects a decreased stress coping [<xref ref-type="bibr" rid="b15-ijerph-06-02934">15</xref>,<xref ref-type="bibr" rid="b16-ijerph-06-02934">16</xref>]. A number of studies have demonstrated VE after myocardial infarction [<xref ref-type="bibr" rid="b17-ijerph-06-02934">17</xref>], and after stroke [<xref ref-type="bibr" rid="b16-ijerph-06-02934">16</xref>]. Moreover, exhaustion has considered being of importance for rehabilitation [<xref ref-type="bibr" rid="b18-ijerph-06-02934">18</xref>], and treating exhaustion has been suggested as a strategy to improve the cardiovascular health [<xref ref-type="bibr" rid="b19-ijerph-06-02934">19</xref>]. Our recent study has shown that VE may contribute to an increased risk of early atherosclerosis in young healthy adults [<xref ref-type="bibr" rid="b20-ijerph-06-02934">20</xref>].</p>
<p>The combined effects of VE and endothelial function on atherosclerosis have not been investigated. The current study was designed to examine this issue. That is, we investigated the interactive effect of VE and endothelial dysfunction, measured by FMD, on preclinical atherosclerosis, assessed by carotid IMT, in young healthy adults aged 24–39 years. Likewise, we examined the interactive effect of VE and CAC on carotid IMT. Based on previous findings that VE is associated with heart diseases [<xref ref-type="bibr" rid="b15-ijerph-06-02934">15</xref>–<xref ref-type="bibr" rid="b18-ijerph-06-02934">18</xref>], and endothelial dysfunction (low FMD) or reduced arterial elasticity (reduced CAC level) are associated with cardiovascular risk [<xref ref-type="bibr" rid="b1-ijerph-06-02934">1</xref>], we hypothesized (1) that a high level of VE in combination with impaired endothelial function (low FMD) or lower arterial elasticity (reduced CAC level) may be related to preclinical atherosclerosis. Furthermore, we hypothesized (2) that these interactions would be most strongly present at the very lowest levels of FMD and CAC and (3) that traditional cardiovascular risk factors would mediate the association.</p>
<p>To evaluate whether the cardiovascular risk factors may mediate the interactive effect of VE and FMD on carotid IMT or may contribute to the interactive effect of VE and CAC on IMT, we took into account the effects of cardiovascular risk factors associated with ultrasound variables in Cardiovascular Risk in Young Finns (CRYF) study [<xref ref-type="bibr" rid="b21-ijerph-06-02934">21</xref>–<xref ref-type="bibr" rid="b23-ijerph-06-02934">23</xref>], and some other cardiovascular risk factors found important. Thus risk factors, such as serum LDL-cholesterol levels, serum HDL-cholesterol levels, triglyceride levels, serum insulin level, systolic and diastolic blood pressure, were included in the current study.</p></sec>
<sec sec-type="methods">
<label>2.</label>
<title>Methods</title>
<sec sec-type="subjects">
<label>2.1.</label>
<title>Subjects</title>
<p>The participants are from the sample of ongoing prospective epidemiological Cardiovascular Risk in Young Finns (CRYF) study [<xref ref-type="bibr" rid="b24-ijerph-06-02934">24</xref>]. The CRYF study was started in 1980 to investigate the development of risk factors for coronary heart disease in children, adolescents and young adults from different parts of Finland. Originally 3,596 healthy Finnish children, adolescents, and young adults aged 3–18 years participated in the first cross-sectional study in 1980. The design of the CRYF study has recently been described in detail [<xref ref-type="bibr" rid="b24-ijerph-06-02934">24</xref>]. In the original CRYF sample, carotid IMT, CAC, and brachial FMD were measured in 2001. Complete data on carotid and brachial artery ultrasound measurements were available for 2,109 subjects aged 24 to 39 years (in 2001). Valid VE questionnaires were obtained from 2,080 participants (in 2001). The final sample comprised 1,596 subjects. The study followed the guiding principles of the Helsinki Declaration and was approved by the local ethics committees. All subjects gave their written, informed consent.</p></sec>
<sec>
<label>2.2.</label>
<title>Vital Exhaustion</title>
<p>Vital exhaustion was assessed with the Maastricht Questionnaire, a 21-item checklist of signs and symptoms of exhaustion [<xref ref-type="bibr" rid="b25-ijerph-06-02934">25</xref>]. Maastricht Questionnaire has been designed for self-application and specially developed to assess the feelings of vital exhaustion [<xref ref-type="bibr" rid="b25-ijerph-06-02934">25</xref>]. Cronbach’s alpha was 0.92, indicating good reliability. Each of the items was rated on a three-point scale, ranging from 0 to 2. The mean score of all items was used to index the level of VE. The questionnaire was sent to the participants to be completed at home.</p></sec>
<sec>
<label>2.3.</label>
<title>Ultrasound Imaging</title>
<p>Ultrasound studies of the carotid and brachial arteries were performed using Sequoia 512 ultrasound mainframes (Acuson, Mountain View, CA, USA) with 13.0 MHz linear array transducer, as previously described [<xref ref-type="bibr" rid="b1-ijerph-06-02934">1</xref>,<xref ref-type="bibr" rid="b21-ijerph-06-02934">21</xref>–<xref ref-type="bibr" rid="b23-ijerph-06-02934">23</xref>]. To assess intra-individual reproducibility of ultrasound measurements, 57 subjects were re-examined three months after the initial visit (2.5% random sample) [<xref ref-type="bibr" rid="b1-ijerph-06-02934">1</xref>].</p></sec>
<sec>
<label>2.4.</label>
<title>Carotid Intima-Media Thickness, IMT</title>
<p>Carotid IMT was measured on the posterior (far) wall of the left carotid artery. At least four measurements were taken approximately 10 mm proximal to the bifurcation to derive mean carotid IMT. The between-visit coefficient of variation (CV) of IMT measurements was 6.4% and the intra-observer CV was 3.4% [<xref ref-type="bibr" rid="b1-ijerph-06-02934">1</xref>].</p></sec>
<sec>
<label>2.5.</label>
<title>Brachial Flow-Mediated Dilatation, FMD</title>
<p>To assess brachial FMD, the left brachial artery diameter was measured both at rest and during reactive hyperemia. Increased flow was induced by inflation of a pneumatic tourniquet placed around the forearm to a pressure of 250 mm Hg for 4.5 min, followed by a release [<xref ref-type="bibr" rid="b22-ijerph-06-02934">22</xref>]. Arterial diameter was measured at end-diastole at a fixed distance from an anatomic marker at rest and 40, 60 and 80 s after cuff release. The vessel diameter in scans after reactive hyperemia was expressed as the percentage relative to resting scan. The average of three measurements at each time point was used to derive the maximum FMD (the greatest value between 40 to 80 s). All ultrasound scans were analyzed by a single reader blinded to the subject’s details. The between-visit coefficient of variation for brachial diameter was 3.2% and for FMD 26.0% [<xref ref-type="bibr" rid="b22-ijerph-06-02934">22</xref>]. Intra-observer CV was 1.2% for brachial diameter, and 15.3% for FMD [<xref ref-type="bibr" rid="b1-ijerph-06-02934">1</xref>].</p></sec>
<sec>
<label>2.6.</label>
<title>Carotid Artery Compliance, CAC</title>
<p>Several moving image clips of the beginning of the carotid bifurcation and the common carotid artery with a duration of 5 s were acquired and stored in digital format for subsequent offline analysis. The best quality cardiac cycle was selected from the clip images. The carotid diameter was measured at least twice (spatial measurements) in end-diastole and end-systole, respectively. The mean of the measurements was used as the end-diastolic or end-systolic diameter. Blood pressure was measured during the ultrasound study with an automated sphygmomanometer (Omron M4, Omron Matsusaka Co., Ltd, Japan). Ultrasound and concomitant brachial blood pressure measurements were used to calculate carotid compliance (CAC = [(Ds – Dd)/Dd]/(Ps – Pd), where Dd is diastolic diameter, Ds is systolic diameter, Ps is systolic blood pressure, and Pd is diastolic blood pressure). The between-visit CV was 2.7% for diastolic diameter and 16.3% for CAC [<xref ref-type="bibr" rid="b23-ijerph-06-02934">23</xref>]. Intra-observer CV was 1.4% for diastolic diameter, and 13.6% for CAC [<xref ref-type="bibr" rid="b1-ijerph-06-02934">1</xref>].</p></sec>
<sec sec-type="intro">
<label>2.7.</label>
<title>Clinical Characteristics and Cardiovascular Risk Factors</title>
<p>We took into account the effects of serum LDL-cholesterol levels, serum HDL-cholesterol levels, triglyceride levels, serum insulin level, systolic and diastolic blood pressure. For the determination of serum lipoprotein levels, venous blood samples were drawn after an overnight fast. All determinations were done using standard methods [<xref ref-type="bibr" rid="b26-ijerph-06-02934">26</xref>]. All measurements of lipid levels were performed in duplicate in the same laboratory. Serum insulin was measured by microparticle enzyme immunoassay kit (Abbott Laboratories, Diagnostic Division, Dainabot, Japan). Blood pressure was measured with a random-zero sphygmomanometer. Average of three measurements was used in the analysis. Blood pressure was included into analyses because it had previously been shown to predict IMT among young adults from 33 to 39 years [<xref ref-type="bibr" rid="b21-ijerph-06-02934">21</xref>].</p></sec>
<sec>
<label>2.8.</label>
<title>Statistical Analyses</title>
<p>The interactions between FMD and VE, and between CAC and VE, in predicting carotid IMT were tested using linear regression techniques (SPSS Version 16.0). In the first model, the main effects of age, sex, VE, FMD, and baseline brachial diameter, as well as the interaction between FMD and VE, were included in the regression analyses when examining the interaction between FMD and VE in predicting IMT. In the second model, the main effects of the risk factors (serum LDL-cholesterol levels, serum HDL-cholesterol levels, triglyceride levels, serum insulin level, systolic blood pressure and diastolic blood pressure) were additionally included. Similar analyze were calculated for CAC × VE interaction. In the third model, the main effects of age, sex, VE, and CAC, as well as the interaction of CAC with VE, were included in the regression model testing the interaction between CAC and VE. In the forth model, the main effects of the risk factors were additionally included. The analyses were carried out in the whole sample and in the low, medium and high FMD (<xref ref-type="table" rid="t2-ijerph-06-02934">Table 2</xref>) and CAC groups (<xref ref-type="table" rid="t3-ijerph-06-02934">Table 3</xref>) separately.</p>
<p>When FMD was categorized, the lowest 30% and the highest 30% were classified into groups of low (FMD: −1.96–5.54%; n = 479) and high (FMD: 10.02–24.84%; n = 479) FMD responses, respectively. The values between the 30th and 70th percentiles were considered as representing a medium FMD response (FMD: 5.55–10.01%; n = 638). The same method was used when categorizing the CAC values (low CAC: 0.25–1.75%/10 mmHg, n = 479; medium CAC: 1.76–2.55%/10 mmHg, n = 638; high CAC: 2.56–5.31(%/10 mmHg, n = 479). The analyses were conducted separately for the low, medium, and high FMD and CAC groups using the regression models described above. Vital exhaustion and ultrasound measures included in the interactions were centralized to avoid multicollinearity [<xref ref-type="bibr" rid="b27-ijerph-06-02934">27</xref>].</p></sec></sec>
<sec sec-type="results">
<label>3.</label>
<title>Results</title>
<p>The mean values for the study parameters are presented in <xref ref-type="table" rid="t1-ijerph-06-02934">Tables 1</xref>–<xref ref-type="table" rid="t3-ijerph-06-02934">3</xref>.</p>
<p>Linear regression analyses showed that VE was not related to IMT when the analysis was performed for all participants (p = 0.895, N = 1,596 for the main effect of VE), nor in any FMD or CAC group (p ≥ 0.426 and p ≥ 0.554, respectively). FMD was negatively marginally significantly related to IMT in the whole sample (β = −0.045; p = 0.075, N = 1,596). However, FMD was not related to IMT in any FMD group (p ≥ 0.276). Likewise, CAC was negatively marginally significantly related to IMT in the whole sample (β = −0.046; p = 0.053; N = 1,596). When the analyses were performed separately in different CAC groups, CAC was shown to be negatively marginally significantly related to IMT only among medium CAC individuals (β = −0.074; p = 0.061; N = 638). In addition, VE was negatively significantly related to FMD in the whole population (β = −0.056; p = 0.025; N = 1,596). However, VE was not related to FMD in any FMD group (p ≥ 0.301). VE was not related to CAC when the analysis was performed in the whole sample (p = 0.890, N = 1,596), nor in any CAC group (p ≥ 0.541).</p>
<sec>
<label>3.1.</label>
<title>Flow-Mediated Dilatation x Vital Exhaustion Interaction in Predicting Intima-Media Thickness</title>
<p><xref ref-type="table" rid="t4-ijerph-06-02934">Table 4</xref> presents the results of linear regression analyses of interactions of FMD with VE for IMT performed a) for all participants together and b) separately for participants with low, medium, and high FMD responses. The interaction of FMD and VE for IMT was found to be non-significant in the whole sample (p = 0.992) and remained non-significant after adjusting for additional cardiovascular risk factors (p = 0.704).</p>
<p>The FMD × VE interaction was significant on IMT (p = 0.044) only in subjects with a low FMD status, whereas this interaction was marginally significant (p = 0.092) after adjusting for cardiovascular risk factors. Further linear regression analyses conducted separately for high VE (N = 228) and low VE (N = 251) participants (median split) from the low FMD response group showed that, among participants with high VE, lower FMD responses predicted higher IMT (β = −0.147; p = 0.027; N = 228). This association was non-significant in low VE subjects from this FMD group (β = 0.053; p = 0.404; N = 251).</p></sec>
<sec>
<label>3.2.</label>
<title>Carotid Artery Compliance × Vital Exhaustion Interaction in Predicting Intima-Media Thickness</title>
<p><xref ref-type="table" rid="t5-ijerph-06-02934">Table 5</xref> shows the results of linear regression analyses of interactions of CAC with VE for IMT (a) for all participants together and (b) separately for participants with low, medium, and high CAC values. The interaction of CAC and VE for IMT was non-significant when the analysis was carried out in the whole sample (p = 0.390) and this interaction was also non-significant in a model adjusted with cardiovascular risk factors (p = 0.574). When the analyses were performed separately for low, medium, and high CAC individuals, the CAC × VE interaction was significant (p = 0.039) for IMT only in participants with a low CAC status. Further linear regression analyses performed separately for the high (N = 247) and low VE (N = 232) individuals (median split) from the low CAC group indicated that low CAC predicted high IMT levels only marginally significantly among high VE participants (β = −0.112; p = 0.067; N = 247), and was unrelated to IMT in low VE participants (β = 0.013; p = 0.849; N = 232). The interaction of CAC and VE for IMT was non-significant in a model adjusted with cardiovascular risk factors in the low and medium CAC responses group (p = 0.423 and p = 0.845, respectively) and marginally significant in the high CAC responses group (p = 0.077).</p></sec></sec>
<sec sec-type="discussion">
<label>4.</label>
<title>Discussion</title>
<p>According to the response-to-injury model of atherosclerosis, impaired systemic endothelial function indicating by a low FMD response [<xref ref-type="bibr" rid="b7-ijerph-06-02934">7</xref>] is an early dysfunctional factor for atherosclerosis development [<xref ref-type="bibr" rid="b2-ijerph-06-02934">2</xref>]. In line with this model, we found in the current study a significant interaction between FMD and VE for IMT only among participants with low FMD values, not among those who had medium or high FMD values that may indicate good vascular health. Our results imply that VE was related to an increased carotid IMT only among subjects with the very lowest FMD response.</p>
<p>These results are in line with the findings that long-term psychosocial stress, such as chronic life stress, accelerates atherosclerosis [<xref ref-type="bibr" rid="b3-ijerph-06-02934">3</xref>]. To our knowledge, the combined effects of VE and the standard atherosclerosis risk factors are not well-documented. Only a few studies have related VE components to ultrasonic measurements of carotid atherosclerosis. In the Kuopio Ischemic Heart Disease study, hopelessness (a component of VE) was related to increased carotid IMT among 900 middle-aged men [<xref ref-type="bibr" rid="b28-ijerph-06-02934">28</xref>]. Likewise, negative feelings (a part of VE) have been shown to be related to increased progression of carotid IMT in 94 men with hypertension [<xref ref-type="bibr" rid="b29-ijerph-06-02934">29</xref>]. In addition, chronic work stress has been associated with increased IMT levels in the CRYF study [<xref ref-type="bibr" rid="b13-ijerph-06-02934">13</xref>]. On the other hand, in the CRYF study, we have previously shown that brachial FMD is inversely related to carotid IMT [<xref ref-type="bibr" rid="b22-ijerph-06-02934">22</xref>]. In addition, we have observed that young adults with high levels of cardiovascular risk factors are at increased risk of having thickened carotid IMT’s, especially when they have evidence of endothelial dysfunction (impaired brachial FMD) [<xref ref-type="bibr" rid="b22-ijerph-06-02934">22</xref>].</p>
<p>Additionally, VE was found in the present study to be negatively related to FMD in the whole population. This suggests that VE may contribute to endothelial dysfunction. This suggestion is in agreement with the findings demonstrating that chronic psychosocial stress impairs endothelial function [<xref ref-type="bibr" rid="b14-ijerph-06-02934">14</xref>]. However, VE was not related to FMD in low FMD group. It seems that this association should be tested in a larger sample of low FMD individuals. Future studies are needed to explore possible causal effect of VE on vascular health.</p>
<p>The mechanisms of translations of chronic stress, including VE, into vascular damages and atherosclerosis progression are not fully established. Appels suggested that VE is causally related to the coronary heart disease events through the neuroendocrine mechanisms [<xref ref-type="bibr" rid="b15-ijerph-06-02934">15</xref>]. It has been found that VE leads to changes in sympathetic-parasympathetic balance [<xref ref-type="bibr" rid="b30-ijerph-06-02934">30</xref>] and in the tone of hypothalamic-pituitary-adrenal (HPA) axis, thereby decreasing stress coping [<xref ref-type="bibr" rid="b31-ijerph-06-02934">31</xref>]. These chronic stress-evoked alterations may influence the functioning of cardiovascular system and, therefore, accelerate the atherosclerotic process [<xref ref-type="bibr" rid="b32-ijerph-06-02934">32</xref>]. Both systems (HPA axis and sympathetic-parasympathetic balance) may contribute to vascular disease development and, possibly, may trigger endothelial dysfunction; and these two systems, as well as inflammatory mediators and also cross-talk interactions between these systems, are included into the pathogenesis of atherosclerotic process [<xref ref-type="bibr" rid="b32-ijerph-06-02934">32</xref>].</p>
<p>The second important finding of the present study was a significant interaction effect between CAC and VE on IMT in participants with low CAC values. Our results are in line with the previous findings that measurements of arterial compliance may offer evidence of vascular changes that occur in the first phases of atherosclerotic disease process [<xref ref-type="bibr" rid="b8-ijerph-06-02934">8</xref>] and that reduced arterial compliance reflects early functional atherosclerosis [<xref ref-type="bibr" rid="b33-ijerph-06-02934">33</xref>].</p>
<p>In line with our hypothesis, high VE was related to high IMT in subjects with low arterial elasticity (reflected by a low CAC level). This finding is in line with the concept that chronic stress contributes to the functioning of endothelium [<xref ref-type="bibr" rid="b14-ijerph-06-02934">14</xref>], however, the combined effect of chronic stress assessed by VE and arterial compliance on atherosclerosis has not previously been investigated. Reduced CAC reflects structural abnormalities of the vascular wall which are associated with aging and disease states [<xref ref-type="bibr" rid="b34-ijerph-06-02934">34</xref>]. The mechanism explaining the interactive effect of VE and arterial elasticity on atherosclerosis is not fully established. It is known that VE may elicit alterations in the sympathetic-parasympathetic balance [<xref ref-type="bibr" rid="b30-ijerph-06-02934">30</xref>] or in the tone of the HPA axis [<xref ref-type="bibr" rid="b31-ijerph-06-02934">31</xref>]. These systems may play a role in the development of endothelial dysfunction [<xref ref-type="bibr" rid="b32-ijerph-06-02934">32</xref>]. Endothelial dysfunction may, in turn, lead to structural alterations of the walls of vessels increasing the sensitivity of vasculature to the harmful influences of risk factors [<xref ref-type="bibr" rid="b34-ijerph-06-02934">34</xref>].</p>
<p>In the present study, controlling for the cardiovascular risk factors attenuated the results on FMD × VE interaction on IMT or CAC × VE interaction on IMT to non-significant which implies that the effect of FMD × VE interaction on IMT or CAC × VE interaction on IMT may be mediated through the risk factors. We may also suggest that FMD or CAC may be influenced by the risk factors. Thus, it has been reported in the previous CRYF studies, that brachial FMD response is related with HDL-cholesterol and with blood pressure [<xref ref-type="bibr" rid="b22-ijerph-06-02934">22</xref>,<xref ref-type="bibr" rid="b33-ijerph-06-02934">33</xref>]; and LDL-cholesterol and blood pressure are related with arterial elasticity [<xref ref-type="bibr" rid="b23-ijerph-06-02934">23</xref>,<xref ref-type="bibr" rid="b33-ijerph-06-02934">33</xref>]. Future studies are needed to shed light to complex causal effects.</p>
<p>No significant interactions of VE with FMD and CAC for IMT were found among participants with medium or high FMD or among participants with medium and high CAC, as well as in the whole population. However, this was not an unexpected finding. The relations between VE and heart diseases are very complicated. Healthy subjects may often feel themselves vitally exhausted; however exhaustion itself may have no additional impact to the increased disease risk. Different situation occurs among patients having heart disease or evidence for heart disease. First, a number of studies have demonstrated associations between VE and coronary events [<xref ref-type="bibr" rid="b15-ijerph-06-02934">15</xref>–<xref ref-type="bibr" rid="b18-ijerph-06-02934">18</xref>]. Second, it has been reported that undiagnosed (or preclinical) heart disease may lead to symptoms of exhaustion [<xref ref-type="bibr" rid="b35-ijerph-06-02934">35</xref>]. Based on this data, our finding on VE in combination with poor vascular health influencing the atherosclerotic processes but not among participants with good parameters of endothelium functioning (medium or high FMD and medium or high CAC) seems logical. The vascular health status has been suggested to modify the association between risk factors and atherosclerosis; possible, good vascular health even in a combination with high VE is a favorable factor in relation to the risk of atherosclerosis development. No significant interactions were found in the overall group. Possibly, this is resulted from high prevalence of participants with good vascular health parameters in the current data derived from a population based sample.</p>
<p>According to the present results, chronic stress assessed by VE may be one of the factors influencing the atherosclerotic processes in combination with poor vascular health. The significant interactions between FMD and VE, and between CAC and VE, for IMT were found only in participants with the very lowest FMD and CAC. We can conclude that VE may be harmful in young adults with evidence of endothelial dysfunction or reduced arterial elasticity and therefore may influence the atherosclerotic progression in early life.</p></sec>
<sec>
<label>5.</label>
<title>Methodological Considerations</title>
<p>It is important to note some limitations of the present study. First, we measured carotid IMT from the left carotid artery, not from the internal carotid artery. Multipart determination of carotid IMT involving both internal and common carotid measurements might be more sensitive to atherosclerosis development [<xref ref-type="bibr" rid="b36-ijerph-06-02934">36</xref>]. However, it is known that the common carotid artery IMT is easily visualised and a highly reproducible measurement. The reproducibility of our measurements is comparable with other reports [<xref ref-type="bibr" rid="b37-ijerph-06-02934">37</xref>]. Previous data support the use of the common carotid artery IMT in both studies of risk factor associations and cohort studies [<xref ref-type="bibr" rid="b37-ijerph-06-02934">37</xref>,<xref ref-type="bibr" rid="b38-ijerph-06-02934">38</xref>].</p>
<p>Second, we found relatively large within-subject long-term variation in FMD [<xref ref-type="bibr" rid="b22-ijerph-06-02934">22</xref>] and CAC [<xref ref-type="bibr" rid="b23-ijerph-06-02934">23</xref>] measurements, but the variability in FMD and CAC responses is actually very comparable to that in some earlier reports [<xref ref-type="bibr" rid="b39-ijerph-06-02934">39</xref>–<xref ref-type="bibr" rid="b42-ijerph-06-02934">42</xref>]. The long-term reproducibility of the carotid and brachial diameter measurements was very good, which suggests that much of the variation in FMD and CAC is due to physiological fluctuation. It has been described in the literature, that several factors may affect FMD variation [<xref ref-type="bibr" rid="b43-ijerph-06-02934">43</xref>]. However, part of the variability naturally relates to the error of the method. The large variability of FMD and CAC is a limitation, and the results should be interpreted with caution until replicated in future research.</p>
<p>The present analysis was conducted in participants aged 24 to 39. Our results cannot be generalized to older individuals with more definite atherosclerosis. Also, owing to the cross-sectional nature of the present study, it is impossible to make statements regarding the atherosclerosis progress.</p></sec>
<sec sec-type="conclusions">
<label>6.</label>
<title>Conclusions</title>
<p>Vital exhaustion was shown to exert an effect on IMT in subjects with impaired endothelial responses. The findings are consistent with the idea that risk factors are more harmful if endothelium is not working properly.</p></sec></body>
<back>
<ack>
<p>This study was supported by the Academy of Finland (Academy project numbers: 111056, 124399), Yrjö Jansson’s Foundation (M.H.), Signe and Ane Gyllenberg’s Foundation (L.K.-J. and M.H.), Niilo Helander Foundation (M.H.) and Emil Aaltonen Foundation (M.H.).</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-ijerph-06-02934"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Juonala</surname><given-names>M</given-names></name></person-group><article-title>Cardiovascular risk factors and their associations with markers of subclinical atherosclerosis in young adults. The Cardiovascular Risk in Young Finns Study</article-title><source>Annales Universitatis Turkuensis</source><year>2005</year><fpage>D645</fpage></citation></ref>
<ref id="b2-ijerph-06-02934"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>R</given-names></name></person-group><article-title>The pathogenesis of atherosclerosis: a perspective for the 1990s</article-title><source>Nature</source><year>1993</year><volume>362</volume><fpage>801</fpage><lpage>809</lpage><pub-id pub-id-type="doi">10.1038/362801a0</pub-id><pub-id pub-id-type="pmid">8479518</pub-id></citation></ref>
<ref id="b3-ijerph-06-02934"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rozanski</surname><given-names>A</given-names></name><name><surname>Blumenthal</surname><given-names>JA</given-names></name><name><surname>Davidson</surname><given-names>KW</given-names></name><name><surname>Saab</surname><given-names>PG</given-names></name><name><surname>Kubzansky</surname><given-names>L</given-names></name></person-group><article-title>The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology</article-title><source>J. Am. Coll. Cardiol</source><year>2005</year><volume>45</volume><fpage>637</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2004.12.005</pub-id><pub-id pub-id-type="pmid">15734605</pub-id></citation></ref>
<ref id="b4-ijerph-06-02934"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Corretti</surname><given-names>MC</given-names></name><name><surname>Plotnick</surname><given-names>GD</given-names></name><name><surname>Vogel</surname><given-names>RA</given-names></name></person-group><article-title>Technical aspects of evaluating brachial artery vasodilation using high-frequency ultrasound</article-title><source>Am. J. Physiol</source><year>1995</year><volume>268</volume><fpage>H1397</fpage><lpage>1404</lpage><pub-id pub-id-type="pmid">7733339</pub-id></citation></ref>
<ref id="b5-ijerph-06-02934"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neunteufl</surname><given-names>T</given-names></name><name><surname>Katzenschlager</surname><given-names>R</given-names></name><name><surname>Hassan</surname><given-names>A</given-names></name><name><surname>Klaar</surname><given-names>U</given-names></name><name><surname>Schwarzacher</surname><given-names>S</given-names></name><name><surname>Glogar</surname><given-names>D</given-names></name><name><surname>Bauer</surname><given-names>P</given-names></name><name><surname>Weidinger</surname><given-names>F</given-names></name></person-group><article-title>Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease</article-title><source>Atherosclerosis</source><year>1997</year><volume>129</volume><fpage>111</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/S0021-9150(96)06018-2</pub-id><pub-id pub-id-type="pmid">9069525</pub-id></citation></ref>
<ref id="b6-ijerph-06-02934"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vogel</surname><given-names>RA</given-names></name></person-group><article-title>Measurement of endothelial function by brachial artery flow-mediated vasodilation</article-title><source>Am. J. Cardiol</source><year>2001</year><volume>88</volume><fpage>31</fpage><lpage>34E</lpage></citation></ref>
<ref id="b7-ijerph-06-02934"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cohn</surname><given-names>JN</given-names></name><name><surname>Quyyumi</surname><given-names>AA</given-names></name><name><surname>Hollenberg</surname><given-names>NK</given-names></name><name><surname>Jamerson</surname><given-names>KA</given-names></name></person-group><article-title>Surrogate markers for cardiovascular disease: Functional markers</article-title><source>Circulation</source><year>2004</year><volume>109</volume><fpage>IV31</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">15226249</pub-id></citation></ref>
<ref id="b8-ijerph-06-02934"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arnett</surname><given-names>DK</given-names></name><name><surname>Evans</surname><given-names>GW</given-names></name><name><surname>Riley</surname><given-names>WA</given-names></name></person-group><article-title>Arterial stiffness: a new cardiovascular risk factor?</article-title><source>Am. J. Epidemiol</source><year>1994</year><volume>140</volume><fpage>669</fpage><lpage>682</lpage><pub-id pub-id-type="pmid">7942769</pub-id></citation></ref>
<ref id="b9-ijerph-06-02934"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bots</surname><given-names>ML</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Grobbee</surname><given-names>DE</given-names></name></person-group><article-title>Common carotid intima-media thickness and lower extremity arterial atherosclerosis. The Rotterdam Study</article-title><source>Arterioscler. Thromb</source><year>1994</year><volume>14</volume><fpage>1885</fpage><lpage>1891</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.14.12.1885</pub-id><pub-id pub-id-type="pmid">7981175</pub-id></citation></ref>
<ref id="b10-ijerph-06-02934"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burke</surname><given-names>GL</given-names></name><name><surname>Evans</surname><given-names>GW</given-names></name><name><surname>Riley</surname><given-names>WA</given-names></name><name><surname>Sharrett</surname><given-names>AR</given-names></name><name><surname>Howard</surname><given-names>G</given-names></name><name><surname>Barnes</surname><given-names>RW</given-names></name><name><surname>Rosamond</surname><given-names>W</given-names></name><name><surname>Crow</surname><given-names>RS</given-names></name><name><surname>Rautaharju</surname><given-names>PM</given-names></name><name><surname>Heiss</surname><given-names>G</given-names></name></person-group><article-title>Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study</article-title><source>Stroke</source><year>1995</year><volume>26</volume><fpage>386</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1161/01.STR.26.3.386</pub-id><pub-id pub-id-type="pmid">7886711</pub-id></citation></ref>
<ref id="b11-ijerph-06-02934"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roman</surname><given-names>MJ</given-names></name><name><surname>Naqvi</surname><given-names>TZ</given-names></name><name><surname>Gardin</surname><given-names>JM</given-names></name><name><surname>Gerhard-Herman</surname><given-names>M</given-names></name><name><surname>Jaff</surname><given-names>M</given-names></name><name><surname>Mohler</surname><given-names>E</given-names></name></person-group><article-title>American Society of Echocardiography; Society for Vascular Medicine and Biology. American Society of Echocardiography report. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology</article-title><source>Vasc. Med</source><year>2006</year><volume>11</volume><fpage>201</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1177/1358863x06070511</pub-id><pub-id pub-id-type="pmid">17288128</pub-id></citation></ref>
<ref id="b12-ijerph-06-02934"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lind</surname><given-names>L</given-names></name></person-group><article-title>Arterial compliance and endothelium-dependent vasodilation are independently related to coronary risk in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study</article-title><source>Clin. Physiol. Funct. Imaging</source><year>2008</year><volume>28</volume><fpage>373</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1111/j.1475-097X.2008.00816.x</pub-id><pub-id pub-id-type="pmid">18540875</pub-id></citation></ref>
<ref id="b13-ijerph-06-02934"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hintsanen</surname><given-names>M</given-names></name><name><surname>Kivimäki</surname><given-names>M</given-names></name><name><surname>Elovainio</surname><given-names>M</given-names></name><name><surname>Pulkki-Råback</surname><given-names>L</given-names></name><name><surname>Keskivaara</surname><given-names>P</given-names></name><name><surname>Juonala</surname><given-names>M</given-names></name><name><surname>Raitakari</surname><given-names>OT</given-names></name><name><surname>Keltikangas-Järvinen</surname><given-names>L</given-names></name></person-group><article-title>Job strain and early atherosclerosis: the Cardiovascular Risk in Young Finns Study</article-title><source>Psychosom. Med</source><year>2005</year><volume>67</volume><fpage>740</fpage><lpage>747</lpage><pub-id pub-id-type="doi">10.1097/01.psy.0000181271.04169.93</pub-id><pub-id pub-id-type="pmid">16204432</pub-id></citation></ref>
<ref id="b14-ijerph-06-02934"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strawn</surname><given-names>WB</given-names></name><name><surname>Bondjers</surname><given-names>G</given-names></name><name><surname>Kaplan</surname><given-names>JR</given-names></name><name><surname>Manuck</surname><given-names>SB</given-names></name><name><surname>Schwenke</surname><given-names>DC</given-names></name><name><surname>Hansson</surname><given-names>GK</given-names></name><name><surname>Shively</surname><given-names>CA</given-names></name><name><surname>Clarkson</surname><given-names>TB</given-names></name></person-group><article-title>Endothelial dysfunction in response to psychosocial stress in monkeys</article-title><source>Circ. Res</source><year>1991</year><volume>68</volume><fpage>1270</fpage><lpage>1279</lpage><pub-id pub-id-type="doi">10.1161/01.RES.68.5.1270</pub-id><pub-id pub-id-type="pmid">2018991</pub-id></citation></ref>
<ref id="b15-ijerph-06-02934"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Appels</surname><given-names>A</given-names></name><name><surname>Mulder</surname><given-names>P</given-names></name></person-group><article-title>Fatigue and heart disease. The association between “vital exhaustion” and past, present and future coronary heart disease</article-title><source>J. Psychosom. Res</source><year>1989</year><volume>33</volume><fpage>727</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1016/0022-3999(89)90088-3</pub-id><pub-id pub-id-type="pmid">2621676</pub-id></citation></ref>
<ref id="b16-ijerph-06-02934"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ingles</surname><given-names>JL</given-names></name><name><surname>Eskes</surname><given-names>GA</given-names></name><name><surname>Phillips</surname><given-names>SJ</given-names></name></person-group><article-title>Fatigue after stroke</article-title><source>Arch. Phys. Med. Rehabil</source><year>1999</year><volume>80</volume><fpage>173</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1016/S0003-9993(99)90116-8</pub-id><pub-id pub-id-type="pmid">10025492</pub-id></citation></ref>
<ref id="b17-ijerph-06-02934"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mendes de Leon</surname><given-names>CF</given-names></name><name><surname>Kop</surname><given-names>WJ</given-names></name><name><surname>de Swart</surname><given-names>HB</given-names></name><name><surname>Bar</surname><given-names>FW</given-names></name><name><surname>Appels</surname><given-names>AP</given-names></name></person-group><article-title>Psychosocial characteristics and recurrent events after percutaneous transluminal coronary angioplasty</article-title><source>Am. J. Cardiol</source><year>1996</year><volume>77</volume><fpage>252</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1016/S0002-9149(97)89388-5</pub-id><pub-id pub-id-type="pmid">8607403</pub-id></citation></ref>
<ref id="b18-ijerph-06-02934"><label>18.</label><citation citation-type="confproc"><person-group person-group-type="author"><name><surname>Appels</surname><given-names>A</given-names></name></person-group><article-title>Exhaustion and the onset of sudden cardiac death</article-title><conf-name>Proceedings of the Paper Presentation at 16th World Congress on Psychosomatic Medicine</conf-name><conf-loc>Goteborg, Sweden</conf-loc><year>2001</year></citation></ref>
<ref id="b19-ijerph-06-02934"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Appels</surname><given-names>A</given-names></name></person-group><article-title>Exhaustion and coronary heart disease: the history of a scientific quest</article-title><source>Patient. Educ. Couns</source><year>2004</year><volume>55</volume><fpage>223</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1016/j.pec.2003.09.008</pub-id><pub-id pub-id-type="pmid">15530758</pub-id></citation></ref>
<ref id="b20-ijerph-06-02934"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chumaeva</surname><given-names>N</given-names></name><name><surname>Hintsanen</surname><given-names>M</given-names></name><name><surname>Ravaja</surname><given-names>N</given-names></name><name><surname>Puttonen</surname><given-names>S</given-names></name><name><surname>Heponiemi</surname><given-names>T</given-names></name><name><surname>Pulkki-Råback</surname><given-names>L</given-names></name><name><surname>Juonala</surname><given-names>M</given-names></name><name><surname>Raitakari</surname><given-names>OT</given-names></name><name><surname>Viikari</surname><given-names>JS</given-names></name><name><surname>Keltikangas-Järvinen</surname><given-names>L</given-names></name></person-group><article-title>Interactive effect of long-term mental stress and cardiac stress reactivity on carotid intima-media thickness: the Cardiovascular Risk in Young Finns Study</article-title><source>Stress</source><year>2009</year><volume>12</volume><fpage>283</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1080/10253890802372406</pub-id><pub-id pub-id-type="pmid">18951243</pub-id></citation></ref>
<ref id="b21-ijerph-06-02934"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raitakari</surname><given-names>OT</given-names></name><name><surname>Juonala</surname><given-names>M</given-names></name><name><surname>Kähönen</surname><given-names>M</given-names></name><name><surname>Taittonen</surname><given-names>L</given-names></name><name><surname>Laitinen</surname><given-names>T</given-names></name><name><surname>Mäki-Torkko</surname><given-names>N</given-names></name><name><surname>Järvisalo</surname><given-names>MJ</given-names></name><name><surname>Uhari</surname><given-names>M</given-names></name><name><surname>Jokinen</surname><given-names>E</given-names></name><name><surname>Rönnemaa</surname><given-names>T</given-names></name><name><surname>Åkerblom</surname><given-names>HK</given-names></name><name><surname>Viikari</surname><given-names>JS</given-names></name></person-group><article-title>Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study</article-title><source>JAMA</source><year>2003</year><volume>290</volume><fpage>2277</fpage><lpage>2283</lpage><pub-id pub-id-type="doi">10.1001/jama.290.17.2277</pub-id><pub-id pub-id-type="pmid">14600186</pub-id></citation></ref>
<ref id="b22-ijerph-06-02934"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Juonala</surname><given-names>M</given-names></name><name><surname>Viikari</surname><given-names>J</given-names></name><name><surname>Laitinen</surname><given-names>T</given-names></name><name><surname>Marniemi</surname><given-names>J</given-names></name><name><surname>Helenius</surname><given-names>H</given-names></name><name><surname>Rönnemaa</surname><given-names>T</given-names></name><name><surname>Raitakari</surname><given-names>OT</given-names></name></person-group><article-title>Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the Cardiovascular Risk in Young Finns Study</article-title><source>Circulation</source><year>2004</year><volume>110</volume><fpage>2918</fpage><lpage>2923</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000147540.88559.00</pub-id><pub-id pub-id-type="pmid">15505080</pub-id></citation></ref>
<ref id="b23-ijerph-06-02934"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Juonala</surname><given-names>M</given-names></name><name><surname>Järvisalo</surname><given-names>MJ</given-names></name><name><surname>Mäki-Torkko</surname><given-names>N</given-names></name><name><surname>Kähönen</surname><given-names>M</given-names></name><name><surname>Viikari</surname><given-names>JS</given-names></name><name><surname>Raitakari</surname><given-names>OT</given-names></name></person-group><article-title>Risk factors identified in childhood and decreased carotid artery elasticity in adulthood: the Cardiovascular Risk in Young Finns Study</article-title><source>Circulation</source><year>2005</year><volume>112</volume><fpage>1486</fpage><lpage>1493</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.104.502161</pub-id><pub-id pub-id-type="pmid">16129802</pub-id></citation></ref>
<ref id="b24-ijerph-06-02934"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raitakari</surname><given-names>OT</given-names></name><name><surname>Juonala</surname><given-names>M</given-names></name><name><surname>Rönnemaa</surname><given-names>T</given-names></name><name><surname>Keltikangas-Järvinen</surname><given-names>L</given-names></name><name><surname>Räsänen</surname><given-names>L</given-names></name><name><surname>Pietikäinen</surname><given-names>M</given-names></name><name><surname>Hutri-Kähönen</surname><given-names>N</given-names></name><name><surname>Taittonen</surname><given-names>L</given-names></name><name><surname>Jokinen</surname><given-names>E</given-names></name><name><surname>Marniemi</surname><given-names>J</given-names></name><name><surname>Jula</surname><given-names>A</given-names></name><name><surname>Telama</surname><given-names>R</given-names></name><name><surname>Kähönen</surname><given-names>M</given-names></name><name><surname>Lehtimäki</surname><given-names>T</given-names></name><name><surname>Åkerblom</surname><given-names>HK</given-names></name><name><surname>Viikari</surname><given-names>JS</given-names></name></person-group><article-title>Cohort profile: the Cardiovascular Risk in Young Finns Study</article-title><source>Int. J. Epidemiol</source><year>2008</year><volume>37</volume><fpage>1220</fpage><lpage>1226</lpage><pub-id pub-id-type="doi">10.1093/ije/dym225</pub-id><pub-id pub-id-type="pmid">18263651</pub-id></citation></ref>
<ref id="b25-ijerph-06-02934"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Appels</surname><given-names>A</given-names></name><name><surname>Höppener</surname><given-names>P</given-names></name><name><surname>Mulder</surname><given-names>P</given-names></name></person-group><article-title>A questionnaire to asses premonitory symptoms of myocardial infarction</article-title><source>Int. J. Cardiol</source><year>1987</year><volume>17</volume><fpage>15</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/0167-5273(87)90029-5</pub-id><pub-id pub-id-type="pmid">3666994</pub-id></citation></ref>
<ref id="b26-ijerph-06-02934"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Juonala</surname><given-names>M</given-names></name><name><surname>Viikari</surname><given-names>JS</given-names></name><name><surname>Hutri-Kähönen</surname><given-names>N</given-names></name><name><surname>Pietikainen</surname><given-names>M</given-names></name><name><surname>Jokinen</surname><given-names>E</given-names></name><name><surname>Taittonen</surname><given-names>L</given-names></name><name><surname>Marniemi</surname><given-names>J</given-names></name><name><surname>Rönnemaa</surname><given-names>T</given-names></name><name><surname>Raitakari</surname><given-names>OT</given-names></name></person-group><article-title>The 21-year follow-up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east-west difference</article-title><source>J. Intern. Med</source><year>2004</year><volume>255</volume><fpage>457</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2796.2004.01308.x</pub-id><pub-id pub-id-type="pmid">15049880</pub-id></citation></ref>
<ref id="b27-ijerph-06-02934"><label>27.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Aiken</surname><given-names>LS</given-names></name><name><surname>West</surname><given-names>SG</given-names></name></person-group><source>Multiple Regression: Testing and Interpreting Interactions</source><publisher-name>Sage Publications</publisher-name><publisher-loc>Thousand Oaks, CA, USA</publisher-loc><year>1991</year></citation></ref>
<ref id="b28-ijerph-06-02934"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Everson</surname><given-names>SA</given-names></name><name><surname>Kaplan</surname><given-names>GA</given-names></name><name><surname>Goldberg</surname><given-names>DE</given-names></name><name><surname>Salonen</surname><given-names>R</given-names></name><name><surname>Salonen</surname><given-names>JT</given-names></name></person-group><article-title>Hopelessness and 4-year progression of carotid atherosclerosis. The Kuopio Ischemic Heart Disease Risk Factor Study</article-title><source>Arterioscler. Thromb. Vasc. Biol</source><year>1997</year><volume>17</volume><fpage>1490</fpage><lpage>1495</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.17.8.1490</pub-id><pub-id pub-id-type="pmid">9301625</pub-id></citation></ref>
<ref id="b29-ijerph-06-02934"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Agewall</surname><given-names>S</given-names></name><name><surname>Wikstrand</surname><given-names>J</given-names></name><name><surname>Dahlöf</surname><given-names>C</given-names></name><name><surname>Fagerberg</surname><given-names>B</given-names></name></person-group><article-title>Negative feelings (discontent) predict progress of intima-media thickness of the common carotid artery in treated hypertensive men at high cardiovascular risk</article-title><source>Am. J. Hypertens</source><year>1996</year><volume>9</volume><fpage>545</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.1016/0895-7061(95)00355-X</pub-id><pub-id pub-id-type="pmid">8783778</pub-id></citation></ref>
<ref id="b30-ijerph-06-02934"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keltikangas-Järvinen</surname><given-names>L</given-names></name><name><surname>Heponiemi</surname><given-names>T</given-names></name></person-group><article-title>Vital exhaustion, temperament, and cardiac reactivity in task-induced stress</article-title><source>Biol. Psychol</source><year>2004</year><volume>65</volume><fpage>121</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1016/S0301-0511(03)00112-1</pub-id><pub-id pub-id-type="pmid">14706435</pub-id></citation></ref>
<ref id="b31-ijerph-06-02934"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keltikangas-Järvinen</surname><given-names>L</given-names></name><name><surname>Räikkonen</surname><given-names>K</given-names></name><name><surname>Hautanen</surname><given-names>A</given-names></name><name><surname>Adlercreutz</surname><given-names>H</given-names></name></person-group><article-title>Vital exhaustion, anger expression, and pituitary and adrenocortical hormones. Implications for the insulin resistance syndrome</article-title><source>Atheroscler. Thromb. Vasc. Biol</source><year>1996</year><volume>16</volume><fpage>275</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.16.2.275</pub-id></citation></ref>
<ref id="b32-ijerph-06-02934"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brotman</surname><given-names>DJ</given-names></name><name><surname>Golden</surname><given-names>SH</given-names></name><name><surname>Wittstein</surname><given-names>IS</given-names></name></person-group><article-title>The cardiovascular toll of stress</article-title><source>Lancet</source><year>2007</year><volume>370</volume><fpage>1089</fpage><lpage>1100</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(07)61305-1</pub-id><pub-id pub-id-type="pmid">17822755</pub-id></citation></ref>
<ref id="b33-ijerph-06-02934"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Juonala</surname><given-names>M</given-names></name><name><surname>Kähönen</surname><given-names>M</given-names></name><name><surname>Laitinen</surname><given-names>T</given-names></name><name><surname>Hutri-Kähönen</surname><given-names>N</given-names></name><name><surname>Jokinen</surname><given-names>E</given-names></name><name><surname>Taittonen</surname><given-names>L</given-names></name><name><surname>Pietikäinen</surname><given-names>M</given-names></name><name><surname>Helenius</surname><given-names>H</given-names></name><name><surname>Viikari</surname><given-names>JS</given-names></name><name><surname>Raitakari</surname><given-names>OT</given-names></name></person-group><article-title>Effect of age and sex on carotid intima-media thickness, elasticity and brachial endothelial function in healthy adults: the Cardiovascular Risk in Young Finns Study</article-title><source>Eur. Heart J</source><year>2008</year><volume>29</volume><fpage>1198</fpage><lpage>1206</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehm556</pub-id><pub-id pub-id-type="pmid">18079136</pub-id></citation></ref>
<ref id="b34-ijerph-06-02934"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cohn</surname><given-names>JN</given-names></name></person-group><article-title>Pathophysiologic and prognostic implications of measuring arterial compliance in hypertensive disease</article-title><source>Prog. Cardiovasc. Dis</source><year>1999</year><volume>41</volume><fpage>441</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1016/S0033-0620(99)70020-4</pub-id><pub-id pub-id-type="pmid">10445868</pub-id></citation></ref>
<ref id="b35-ijerph-06-02934"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bloor</surname><given-names>CM</given-names></name></person-group><article-title>Depression: a symptom of coronary artery disease or a pathogenetic factor?</article-title><source>Psychosom. Med</source><year>2000</year><volume>62</volume><fpage>606</fpage><lpage>607</lpage><pub-id pub-id-type="pmid">11020088</pub-id></citation></ref>
<ref id="b36-ijerph-06-02934"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O’Leary</surname><given-names>DH</given-names></name><name><surname>Polak</surname><given-names>JF</given-names></name><name><surname>Kronmal</surname><given-names>RA</given-names></name><name><surname>Manolio</surname><given-names>TA</given-names></name><name><surname>Burke</surname><given-names>GL</given-names></name><name><surname>Wolfson</surname><given-names>SK</given-names><suffix>Jr</suffix></name></person-group><article-title>Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group</article-title><source>N. Engl. J. Med</source><year>1999</year><volume>340</volume><fpage>14</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1056/NEJM199901073400103</pub-id><pub-id pub-id-type="pmid">9878640</pub-id></citation></ref>
<ref id="b37-ijerph-06-02934"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kanters</surname><given-names>SD</given-names></name><name><surname>Algra</surname><given-names>A</given-names></name><name><surname>van Leeuwen</surname><given-names>MS</given-names></name><name><surname>Banga</surname><given-names>JD</given-names></name></person-group><article-title>Reproducibility of <italic>in vivo</italic> carotid intima-media thickness measurements: a review</article-title><source>Stroke</source><year>1997</year><volume>28</volume><fpage>665</fpage><lpage>671</lpage><pub-id pub-id-type="doi">10.1161/01.STR.28.3.665</pub-id><pub-id pub-id-type="pmid">9056629</pub-id></citation></ref>
<ref id="b38-ijerph-06-02934"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crouse</surname><given-names>JR</given-names></name><name><surname>Craven</surname><given-names>TE</given-names></name><name><surname>Hagaman</surname><given-names>AP</given-names></name><name><surname>Bond</surname><given-names>MG</given-names></name></person-group><article-title>Association of coronary disease with segment-specific intimal-medial thickening of the extracranial carotid artery</article-title><source>Circulation</source><year>1995</year><volume>92</volume><fpage>1141</fpage><lpage>1147</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.92.5.1141</pub-id><pub-id pub-id-type="pmid">7648658</pub-id></citation></ref>
<ref id="b39-ijerph-06-02934"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lind</surname><given-names>L</given-names></name><name><surname>Hall</surname><given-names>J</given-names></name><name><surname>Larsson</surname><given-names>A</given-names></name><name><surname>Annuk</surname><given-names>M</given-names></name><name><surname>Fellstrom</surname><given-names>B</given-names></name><name><surname>Lithell</surname><given-names>H</given-names></name></person-group><article-title>Evaluation of endothelium-dependent vasodilation in the human peripheral circulation</article-title><source>Clin. Physiol</source><year>2000</year><volume>20</volume><fpage>440</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2281.2000.00281.x</pub-id><pub-id pub-id-type="pmid">11100391</pub-id></citation></ref>
<ref id="b40-ijerph-06-02934"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Roos</surname><given-names>NM</given-names></name><name><surname>Bots</surname><given-names>ML</given-names></name><name><surname>Schouten</surname><given-names>EG</given-names></name><name><surname>Katan</surname><given-names>MB</given-names></name></person-group><article-title>Within-subject variability of flow-mediated vasodilatation of the brachial artery in healthy men and women: implications for experimental studies</article-title><source>Ultrasound. Med. Biol</source><year>2003</year><volume>29</volume><fpage>401</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1016/S0301-5629(02)00709-3</pub-id><pub-id pub-id-type="pmid">12706191</pub-id></citation></ref>
<ref id="b41-ijerph-06-02934"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jensen-Urstad</surname><given-names>K</given-names></name><name><surname>Rosfors</surname><given-names>S</given-names></name></person-group><article-title>A methodological study of arterial wall function using ultrasound technique</article-title><source>Clin. Physiol</source><year>1997</year><volume>17</volume><fpage>557</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2281.1997.00063.x</pub-id><pub-id pub-id-type="pmid">9413643</pub-id></citation></ref>
<ref id="b42-ijerph-06-02934"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arnett</surname><given-names>DK</given-names></name><name><surname>Chambless</surname><given-names>LE</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Evans</surname><given-names>GW</given-names></name><name><surname>Riley</surname><given-names>W</given-names></name></person-group><article-title>Variability in ultrasonic measurements of arterial stiffness in the Atherosclerosis Risk in Communities study</article-title><source>Ultrasound. Med. Biol</source><year>1999</year><volume>25</volume><fpage>175</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1016/S0301-5629(98)00165-3</pub-id><pub-id pub-id-type="pmid">10320306</pub-id></citation></ref>
<ref id="b43-ijerph-06-02934"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Corretti</surname><given-names>MC</given-names></name><name><surname>Anderson</surname><given-names>TJ</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Celermajer</surname><given-names>DS</given-names></name><name><surname>Charbonneau</surname><given-names>F</given-names></name><name><surname>Creager</surname><given-names>MA</given-names></name><name><surname>Deanfield</surname><given-names>JE</given-names></name><name><surname>Drexler</surname><given-names>H</given-names></name><name><surname>Gerhard-Herman</surname><given-names>M</given-names></name><name><surname>Herrington</surname><given-names>D</given-names></name><name><surname>Vallance</surname><given-names>P</given-names></name><name><surname>Vita</surname><given-names>JA</given-names></name><name><surname>Vogel</surname><given-names>R</given-names></name></person-group><article-title>Guidelines for the ultrasound assessment of endothelial dependent flow-mediated vasodilatation of the brachial artery. A report of the international brachial artery reactivity task force</article-title><source>J. Am. Coll. Cardiol</source><year>2002</year><volume>39</volume><fpage>257</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">11788217</pub-id></citation></ref></ref-list>
<sec sec-type="display-objects">
<title>Tables</title>
<table-wrap id="t1-ijerph-06-02934" position="float">
<label>Table 1.</label>
<caption>
<p>Characteristics of study participants.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="middle" align="left"><bold><italic>Variable</italic></bold></th>
<th valign="middle" align="center"><bold><italic>Mean</italic></bold></th>
<th valign="middle" align="center"><bold><italic>(SD)</italic></bold></th>
<th valign="middle" align="center"><bold><italic>N</italic></bold></th></tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Age in 2001, years (24–39)</td>
<td valign="top" align="center">31.59</td>
<td valign="top" align="center">5.05</td>
<td valign="top" align="center">1,596</td></tr>
<tr>
<td valign="top" align="left">Baseline brachial diameter (mm)</td>
<td valign="top" align="center">3.47</td>
<td valign="top" align="center">0.57</td>
<td valign="top" align="center">1,596</td></tr>
<tr>
<td valign="top" align="left">Flow-mediated dilatation, FMD (%)</td>
<td valign="top" align="center">8.04</td>
<td valign="top" align="center">4.44</td>
<td valign="top" align="center">1,596</td></tr>
<tr>
<td valign="top" align="left">Carotid artery compliance, CAC (%/10 mmHg)</td>
<td valign="top" align="center">2.20</td>
<td valign="top" align="center">0.74</td>
<td valign="top" align="center">1,596</td></tr>
<tr>
<td valign="top" align="left">LDL-cholesterol (mmol/L)</td>
<td valign="top" align="center">3.27</td>
<td valign="top" align="center">0.85</td>
<td valign="top" align="center">1,591</td></tr>
<tr>
<td valign="top" align="left">HDL-cholesterol (mmol/L)</td>
<td valign="top" align="center">1.31</td>
<td valign="top" align="center">0.32</td>
<td valign="top" align="center">1,591</td></tr>
<tr>
<td valign="top" align="left">Triclycerids (mmol/L)</td>
<td valign="top" align="center">1.30</td>
<td valign="top" align="center">0.83</td>
<td valign="top" align="center">1,592</td></tr>
<tr>
<td valign="top" align="left">Insulin (mU/L)</td>
<td valign="top" align="center">7.79</td>
<td valign="top" align="center">5.50</td>
<td valign="top" align="center">992</td></tr>
<tr>
<td valign="top" align="left">Systolic blood pressure (mm Hg)</td>
<td valign="top" align="center">117.08</td>
<td valign="top" align="center">13.12</td>
<td valign="top" align="center">989</td></tr>
<tr>
<td valign="top" align="left">Diastolic blood pressure (mm Hg)</td>
<td valign="top" align="center">70.98</td>
<td valign="top" align="center">10.86</td>
<td valign="top" align="center">989</td></tr>
<tr>
<td valign="top" align="left">Carotid intima-media thickness, IMT (mm)</td>
<td valign="top" align="center">0.58</td>
<td valign="top" align="center">0.09</td>
<td valign="top" align="center">1,596</td></tr>
<tr>
<td valign="top" align="left">Vital Exhaustion, VE</td>
<td valign="top" align="center">0.42</td>
<td valign="top" align="center">0.38</td>
<td valign="top" align="center">1,596</td></tr></tbody></table></table-wrap>
<table-wrap id="t2-ijerph-06-02934" position="float">
<label>Table 2.</label>
<caption>
<p>Study characteristics in subgroups stratified by FMD response.</p></caption>
<table frame="hsides" rules="cols">
<thead>
<tr><th valign="middle" align="left"/>
<th valign="middle" align="center" colspan="3"><bold><italic>Low FMD</italic></bold></th>
<th valign="middle" align="center" colspan="3"><bold><italic>Medium FMD</italic></bold></th>
<th valign="middle" align="center" colspan="3"><bold><italic>High FMD</italic></bold></th></tr>
<tr>
<th valign="middle" align="left" colspan="10"><hr/></th></tr>
<tr>
<th valign="top" align="left"><bold><italic>Variable</italic></bold></th>
<th valign="middle" align="center"><bold><italic>Mean</italic></bold></th>
<th valign="middle" align="center"><bold><italic>(SD)</italic></bold></th>
<th valign="middle" align="center"><bold><italic>N</italic></bold></th>
<th valign="middle" align="center"><bold><italic>Mean</italic></bold></th>
<th valign="middle" align="center"><bold><italic>(SD)</italic></bold></th>
<th valign="middle" align="center"><bold><italic>N</italic></bold></th>
<th valign="middle" align="center"><bold><italic>Mean</italic></bold></th>
<th valign="middle" align="center"><bold><italic>(SD)</italic></bold></th>
<th valign="middle" align="center"><bold><italic>N</italic></bold></th></tr>
<tr>
<th valign="middle" align="left" colspan="10"><hr/></th></tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Age, years (24–39)</td>
<td valign="middle" align="center">31.22</td>
<td valign="middle" align="center">5.26</td>
<td valign="middle" align="center">479</td>
<td valign="middle" align="center">31.57</td>
<td valign="middle" align="center">5.07</td>
<td valign="middle" align="center">638</td>
<td valign="middle" align="center">31.98</td>
<td valign="middle" align="center">4.75</td>
<td valign="middle" align="center">479</td></tr>
<tr>
<td valign="top" align="left">Baseline brachial diameter (mm)</td>
<td valign="top" align="center">3.69</td>
<td valign="top" align="center">0.59</td>
<td valign="top" align="center">479</td>
<td valign="top" align="center">3.51</td>
<td valign="top" align="center">0.56</td>
<td valign="top" align="center">638</td>
<td valign="top" align="center">3.19</td>
<td valign="top" align="center">0.45</td>
<td valign="top" align="center">479</td></tr>
<tr>
<td valign="top" align="left">Flow-mediated dilatation,FMD (%)</td>
<td valign="middle" align="center">3.14</td>
<td valign="middle" align="center">1.72</td>
<td valign="middle" align="center">479</td>
<td valign="middle" align="center">7.75</td>
<td valign="middle" align="center">1.26</td>
<td valign="middle" align="center">638</td>
<td valign="middle" align="center">13.34</td>
<td valign="middle" align="center">2.89</td>
<td valign="middle" align="center">479</td></tr>
<tr>
<td valign="top" align="left">LDL-cholesterol (mmol/L)</td>
<td valign="middle" align="center">3.25</td>
<td valign="middle" align="center">0.85</td>
<td valign="middle" align="center">479</td>
<td valign="middle" align="center">3.27</td>
<td valign="middle" align="center">0.87</td>
<td valign="middle" align="center">636</td>
<td valign="middle" align="center">3.29</td>
<td valign="middle" align="center">0.84</td>
<td valign="middle" align="center">476</td></tr>
<tr>
<td valign="top" align="left">HDL-cholesterol (mmol/L)</td>
<td valign="middle" align="center">1.29</td>
<td valign="middle" align="center">0.30</td>
<td valign="middle" align="center">479</td>
<td valign="middle" align="center">1.29</td>
<td valign="middle" align="center">0.32</td>
<td valign="middle" align="center">636</td>
<td valign="middle" align="center">1.35</td>
<td valign="middle" align="center">0.33</td>
<td valign="middle" align="center">476</td></tr>
<tr>
<td valign="top" align="left">Triclycerids (mmol/L)</td>
<td valign="middle" align="center">1.25</td>
<td valign="middle" align="center">0.68</td>
<td valign="middle" align="center">479</td>
<td valign="middle" align="center">1.36</td>
<td valign="middle" align="center">0.86</td>
<td valign="middle" align="center">637</td>
<td valign="middle" align="center">1.29</td>
<td valign="middle" align="center">0.90</td>
<td valign="middle" align="center">476</td></tr>
<tr>
<td valign="top" align="left">Insulin (mU/L)</td>
<td valign="middle" align="center">7.91</td>
<td valign="middle" align="center">5.99</td>
<td valign="middle" align="center">316</td>
<td valign="middle" align="center">7.80</td>
<td valign="middle" align="center">5.29</td>
<td valign="middle" align="center">391</td>
<td valign="middle" align="center">7.64</td>
<td valign="middle" align="center">5.23</td>
<td valign="middle" align="center">285</td></tr>
<tr>
<td valign="top" align="left">Systolic blood pressure (mm Hg)</td>
<td valign="middle" align="center">117.55</td>
<td valign="middle" align="center">13.46</td>
<td valign="middle" align="center">317</td>
<td valign="middle" align="center">115.80</td>
<td valign="middle" align="center">12.54</td>
<td valign="middle" align="center">386</td>
<td valign="middle" align="center">118.29</td>
<td valign="middle" align="center">13.40</td>
<td valign="middle" align="center">286</td></tr>
<tr>
<td valign="top" align="left">Diastolic blood pressure (mm Hg)</td>
<td valign="middle" align="center">71.92</td>
<td valign="middle" align="center">11.06</td>
<td valign="middle" align="center">317</td>
<td valign="middle" align="center">69.93</td>
<td valign="middle" align="center">10.26</td>
<td valign="middle" align="center">386</td>
<td valign="middle" align="center">71.36</td>
<td valign="middle" align="center">11.32</td>
<td valign="middle" align="center">286</td></tr>
<tr>
<td valign="top" align="left">Carotid intima-media thickness, IMT (mm)</td>
<td valign="middle" align="center">0.58</td>
<td valign="middle" align="center">0.09</td>
<td valign="middle" align="center">479</td>
<td valign="middle" align="center">0.58</td>
<td valign="middle" align="center">0.10</td>
<td valign="middle" align="center">638</td>
<td valign="middle" align="center">0.57</td>
<td valign="middle" align="center">0.09</td>
<td valign="middle" align="center">479</td></tr>
<tr>
<td valign="top" align="left">Vital Exhaustion, VE</td>
<td valign="middle" align="center">0.39</td>
<td valign="middle" align="center">0.35</td>
<td valign="middle" align="center">479</td>
<td valign="middle" align="center">0.42</td>
<td valign="middle" align="center">0.38</td>
<td valign="middle" align="center">638</td>
<td valign="middle" align="center">0.44</td>
<td valign="middle" align="center">0.39</td>
<td valign="middle" align="center">479</td></tr></tbody></table></table-wrap>
<table-wrap id="t3-ijerph-06-02934" position="float">
<label>Table 3.</label>
<caption>
<p>Study characteristics in subgroups stratified by CAC response.</p></caption>
<table frame="hsides" rules="cols">
<thead>
<tr><th valign="middle" align="left"/>
<th valign="middle" align="center" colspan="3"><bold><italic>Low CAC</italic></bold></th>
<th valign="middle" align="center" colspan="3"><bold><italic>Medium CAC</italic></bold></th>
<th valign="middle" align="center" colspan="3"><bold><italic>High CAC</italic></bold></th></tr>
<tr>
<th valign="middle" align="left" colspan="10"><hr/></th></tr>
<tr>
<th valign="top" align="left"><bold><italic>Variable</italic></bold></th>
<th valign="middle" align="center"><bold><italic>Mean</italic></bold></th>
<th valign="middle" align="center"><bold><italic>(SD)</italic></bold></th>
<th valign="middle" align="center"><bold><italic>N</italic></bold></th>
<th valign="middle" align="center"><bold><italic>Mean</italic></bold></th>
<th valign="middle" align="center"><bold><italic>(SD)</italic></bold></th>
<th valign="middle" align="center"><bold><italic>N</italic></bold></th>
<th valign="middle" align="center"><bold><italic>Mean</italic></bold></th>
<th valign="middle" align="center"><bold><italic>(SD)</italic></bold></th>
<th valign="middle" align="center"><bold><italic>N</italic></bold></th></tr>
<tr>
<th valign="middle" align="left" colspan="10"><hr/></th></tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Age, years (24–39)</td>
<td valign="middle" align="center">33.26</td>
<td valign="middle" align="center">4.78</td>
<td valign="middle" align="center">479</td>
<td valign="middle" align="center">31.45</td>
<td valign="middle" align="center">5.05</td>
<td valign="middle" align="center">638</td>
<td valign="middle" align="center">30.10</td>
<td valign="middle" align="center">4.81</td>
<td valign="middle" align="center">479</td></tr>
<tr>
<td valign="top" align="left">Carotid artery compliance, CAC (%/10 mmHg)</td>
<td valign="middle" align="center">1.39</td>
<td valign="middle" align="center">0.28</td>
<td valign="middle" align="center">479</td>
<td valign="middle" align="center">2.15</td>
<td valign="middle" align="center">0.23</td>
<td valign="middle" align="center">638</td>
<td valign="middle" align="center">3.09</td>
<td valign="middle" align="center">0.45</td>
<td valign="middle" align="center">479</td></tr>
<tr>
<td valign="top" align="left">LDL-cholesterol (mmol/L)</td>
<td valign="middle" align="center">3.45</td>
<td valign="middle" align="center">0.88</td>
<td valign="middle" align="center">478</td>
<td valign="middle" align="center">3.24</td>
<td valign="middle" align="center">0.88</td>
<td valign="middle" align="center">635</td>
<td valign="middle" align="center">3.13</td>
<td valign="middle" align="center">0.75</td>
<td valign="middle" align="center">478</td></tr>
<tr>
<td valign="top" align="left">HDL-cholesterol (mmol/L)</td>
<td valign="middle" align="center">1.26</td>
<td valign="middle" align="center">0.33</td>
<td valign="middle" align="center">478</td>
<td valign="middle" align="center">1.31</td>
<td valign="middle" align="center">0.31</td>
<td valign="middle" align="center">635</td>
<td valign="middle" align="center">1.35</td>
<td valign="middle" align="center">0.31</td>
<td valign="middle" align="center">478</td></tr>
<tr>
<td valign="top" align="left">Triclycerids (mmol/L)</td>
<td valign="middle" align="center">1.49</td>
<td valign="middle" align="center">0.94</td>
<td valign="middle" align="center">479</td>
<td valign="middle" align="center">1.28</td>
<td valign="middle" align="center">0.89</td>
<td valign="middle" align="center">635</td>
<td valign="middle" align="center">1.14</td>
<td valign="middle" align="center">0.52</td>
<td valign="middle" align="center">478</td></tr>
<tr>
<td valign="top" align="left">Insulin (mU/L)</td>
<td valign="middle" align="center">7.92</td>
<td valign="middle" align="center">4.71</td>
<td valign="middle" align="center">307</td>
<td valign="middle" align="center">7.46</td>
<td valign="middle" align="center">4.69</td>
<td valign="middle" align="center">390</td>
<td valign="middle" align="center">8.08</td>
<td valign="middle" align="center">7.04</td>
<td valign="middle" align="center">295</td></tr>
<tr>
<td valign="top" align="left">Systolic blood pressure (mm Hg)</td>
<td valign="middle" align="center">117.64</td>
<td valign="middle" align="center">13.52</td>
<td valign="middle" align="center">304</td>
<td valign="middle" align="center">116.40</td>
<td valign="middle" align="center">12.78</td>
<td valign="middle" align="center">389</td>
<td valign="middle" align="center">117.40</td>
<td valign="middle" align="center">13.16</td>
<td valign="middle" align="center">296</td></tr>
<tr>
<td valign="top" align="left">Diastolic blood pressure (mm Hg)</td>
<td valign="middle" align="center">70.49</td>
<td valign="middle" align="center">10.88</td>
<td valign="middle" align="center">304</td>
<td valign="middle" align="center">70.71</td>
<td valign="middle" align="center">10.77</td>
<td valign="middle" align="center">389</td>
<td valign="middle" align="center">71.85</td>
<td valign="middle" align="center">10.93</td>
<td valign="middle" align="center">296</td></tr>
<tr>
<td valign="middle" align="left">Carotid intima-media thickness, IMT (mm)</td>
<td valign="middle" align="center">0.59</td>
<td valign="middle" align="center">0.10</td>
<td valign="middle" align="center">479</td>
<td valign="middle" align="center">0.58</td>
<td valign="middle" align="center">0.09</td>
<td valign="middle" align="center">638</td>
<td valign="middle" align="center">0.58</td>
<td valign="middle" align="center">0.10</td>
<td valign="middle" align="center">479</td></tr>
<tr>
<td valign="top" align="left">Vital Exhaustion, VE</td>
<td valign="middle" align="center">0.42</td>
<td valign="middle" align="center">0.38</td>
<td valign="middle" align="center">479</td>
<td valign="middle" align="center">0.42</td>
<td valign="middle" align="center">0.38</td>
<td valign="middle" align="center">638</td>
<td valign="middle" align="center">0.42</td>
<td valign="middle" align="center">0.37</td>
<td valign="middle" align="center">479</td></tr></tbody></table></table-wrap>
<table-wrap id="t4-ijerph-06-02934" position="float">
<label>Table 4.</label>
<caption>
<p>Regression analysis of interaction between flow-mediated dilatation and vital exhaustion in predicting IMT.</p></caption>
<table frame="box" rules="cols">
<thead>
<tr><th valign="middle" align="left"/>
<th valign="middle" align="left"><bold>R<sup>2</sup><xref ref-type="table-fn" rid="tfn4-ijerph-06-02934">*</xref></bold></th>
<th valign="middle" align="left"><bold>β<xref ref-type="table-fn" rid="tfn5-ijerph-06-02934">**</xref></bold></th>
<th valign="middle" align="left"><bold>R<sup>2</sup><xref ref-type="table-fn" rid="tfn6-ijerph-06-02934">***</xref> change</bold></th>
<th valign="middle" align="left"><bold>p</bold></th>
<th valign="middle" align="left"><bold>N</bold></th></tr>
<tr>
<th valign="middle" align="left" colspan="6"><hr/></th></tr></thead>
<tbody>
<tr>
<td valign="middle" align="center" colspan="6"><bold>All FMD responses</bold></td></tr>
<tr>
<td valign="middle" align="left" colspan="6"><hr/></td></tr>
<tr>
<td valign="middle" align="left">FMD x VE<xref ref-type="table-fn" rid="tfn3-ijerph-06-02934">1</xref></td>
<td valign="middle" align="left">0.129</td><td valign="middle" align="left"/>
<td valign="middle" align="left">0.000</td>
<td valign="middle" align="left">0.992</td>
<td valign="middle" align="left">1,596</td></tr>
<tr>
<td valign="middle" align="left"><xref ref-type="table-fn" rid="tfn7-ijerph-06-02934">#</xref>FMD x VE<xref ref-type="table-fn" rid="tfn3-ijerph-06-02934">1</xref></td>
<td valign="middle" align="left">0.177</td><td valign="middle" align="left"/>
<td valign="middle" align="left">0.000</td>
<td valign="middle" align="left">0.704</td>
<td valign="middle" align="left">1,596</td></tr>
<tr>
<td valign="middle" align="left" colspan="6"><hr/></td></tr>
<tr>
<td valign="middle" align="center" colspan="6"><bold>Low FMD responses (30%)</bold></td></tr>
<tr>
<td valign="middle" align="left" colspan="6"><hr/></td></tr>
<tr>
<td valign="middle" align="left"><italic>FMD x VE</italic></td>
<td valign="middle" align="center"><italic>0.139</italic></td><td valign="middle" align="center"/>
<td valign="middle" align="center"><bold><italic>0.007</italic></bold></td>
<td valign="middle" align="center"><bold><italic>0.044</italic></bold></td>
<td valign="middle" align="center"><italic>479</italic></td></tr>
<tr>
<td valign="middle" align="left"><italic>sex</italic></td><td valign="middle" align="center"/>
<td valign="middle" align="center"><italic>0.063</italic></td><td valign="middle" align="center"/>
<td valign="middle" align="center"><italic>0.349</italic></td><td valign="middle" align="center"/></tr>
<tr>
<td valign="middle" align="left"><italic>age</italic></td><td valign="middle" align="center"/>
<td valign="middle" align="center"><italic>0.318</italic></td><td valign="middle" align="center"/>
<td valign="middle" align="center"><italic>0.000</italic></td><td valign="middle" align="center"/></tr>
<tr>
<td valign="middle" align="left"><italic>baseline brachial diameter</italic></td><td valign="middle" align="center"/>
<td valign="middle" align="center"><italic>0.181</italic></td><td valign="middle" align="center"/>
<td valign="middle" align="center"><italic>0.007</italic></td><td valign="middle" align="center"/></tr>
<tr>
<td valign="middle" align="left"><italic>FMD</italic></td><td valign="middle" align="center"/>
<td valign="middle" align="center"><italic>−0.083</italic></td><td valign="middle" align="center"/>
<td valign="middle" align="center"><italic>0.185</italic></td><td valign="middle" align="center"/></tr>
<tr>
<td valign="middle" align="left"><italic>VE</italic></td><td valign="middle" align="center"/>
<td valign="middle" align="center"><italic>0.141</italic></td><td valign="middle" align="center"/>
<td valign="middle" align="center"><italic>0.103</italic></td><td valign="middle" align="center"/></tr>
<tr>
<td valign="middle" align="left"><xref ref-type="table-fn" rid="tfn7-ijerph-06-02934">#</xref>FMD x VE<xref ref-type="table-fn" rid="tfn3-ijerph-06-02934">1</xref></td>
<td valign="middle" align="center"><italic>0.210</italic></td><td valign="middle" align="center"/>
<td valign="middle" align="center"><italic>0.007</italic></td>
<td valign="middle" align="center"><italic>0.092</italic></td>
<td valign="middle" align="center"><italic>479</italic></td></tr>
<tr>
<td valign="middle" align="left" colspan="6"><hr/></td></tr>
<tr>
<td valign="middle" align="center" colspan="6"><bold>Medium FMD responses (40%)</bold></td></tr>
<tr>
<td valign="middle" align="left" colspan="6"><hr/></td></tr>
<tr>
<td valign="middle" align="left">FMD x VE<xref ref-type="table-fn" rid="tfn3-ijerph-06-02934">1</xref></td>
<td valign="middle" align="center">0.131</td><td valign="middle" align="center"/>
<td valign="middle" align="center">0.000</td>
<td valign="middle" align="center">0.992</td>
<td valign="middle" align="center">638</td></tr>
<tr>
<td valign="middle" align="left"><xref ref-type="table-fn" rid="tfn7-ijerph-06-02934">#</xref>FMD x VE<xref ref-type="table-fn" rid="tfn3-ijerph-06-02934">1</xref></td>
<td valign="middle" align="center">0.187</td><td valign="middle" align="center"/>
<td valign="middle" align="center">0.004</td>
<td valign="middle" align="center">0.186</td>
<td valign="middle" align="center">638</td></tr>
<tr>
<td valign="middle" align="left" colspan="6"><hr/></td></tr>
<tr>
<td valign="middle" align="center" colspan="6"><bold>High FMD responses (30%)</bold></td></tr>
<tr>
<td valign="middle" align="left" colspan="6"><hr/></td></tr>
<tr>
<td valign="middle" align="left">FMD x VE<xref ref-type="table-fn" rid="tfn3-ijerph-06-02934">1</xref></td>
<td valign="middle" align="center">0.125</td><td valign="middle" align="center"/>
<td valign="middle" align="center">0.000</td>
<td valign="middle" align="center">0.726</td>
<td valign="middle" align="center">479</td></tr>
<tr>
<td valign="middle" align="left"><xref ref-type="table-fn" rid="tfn7-ijerph-06-02934">#</xref>FMD x VE<xref ref-type="table-fn" rid="tfn3-ijerph-06-02934">1</xref></td>
<td valign="middle" align="center">0.199</td><td valign="middle" align="center"/>
<td valign="middle" align="center">0.002</td>
<td valign="middle" align="center">0.408</td>
<td valign="middle" align="center">479</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn1-ijerph-06-02934">
<p>VE-vital exhaustion</p></fn><fn id="tfn2-ijerph-06-02934">
<p>FMD-flow-mediated dilatation (%)</p></fn><fn id="tfn3-ijerph-06-02934">
<label>1</label>
<p>Main effects were included in each analysis but they are presented for low FMD group only</p></fn><fn id="tfn4-ijerph-06-02934">
<label>*</label>
<p>Calculated for the whole model</p></fn><fn id="tfn5-ijerph-06-02934">
<label>**</label>
<p>Refers to main effects</p></fn><fn id="tfn6-ijerph-06-02934">
<label>***</label>
<p>Refers to the interaction term</p></fn><fn id="tfn7-ijerph-06-02934">
<label>#</label>
<p>Additionally adjusted for cardiovascular risk factors: LDL-cholesterol, HDL-cholesterol, triglycerides, insulin, systolic and diastolic blood pressure</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="t5-ijerph-06-02934" position="float">
<label>Table 5.</label>
<caption>
<p>Regression analysis of interactions between carotid artery compliance and vital exhaustion in predicting IMT.</p></caption>
<table frame="box" rules="all">
<thead>
<tr><th valign="middle" align="left"/>
<th valign="middle" align="left"><bold>R<sup>2</sup><xref ref-type="table-fn" rid="tfn11-ijerph-06-02934">*</xref></bold></th>
<th valign="middle" align="left"><bold>β<xref ref-type="table-fn" rid="tfn12-ijerph-06-02934">**</xref></bold></th>
<th valign="middle" align="left"><bold>R<sup>2</sup><xref ref-type="table-fn" rid="tfn13-ijerph-06-02934">***</xref> change</bold></th>
<th valign="middle" align="left"><bold>p</bold></th>
<th valign="middle" align="left"><bold>N</bold></th></tr></thead>
<tbody>
<tr>
<td valign="middle" align="center" colspan="6"><bold>All CAC responses</bold></td></tr>
<tr>
<td valign="middle" align="left">CAC × VE<xref ref-type="table-fn" rid="tfn10-ijerph-06-02934">1</xref></td>
<td valign="middle" align="center">0.126</td><td valign="middle" align="center"/>
<td valign="middle" align="center">0.000</td>
<td valign="middle" align="center">0.390</td>
<td valign="middle" align="center">1596</td></tr>
<tr>
<td valign="middle" align="left"><xref ref-type="table-fn" rid="tfn14-ijerph-06-02934">#</xref>CAC × VE<xref ref-type="table-fn" rid="tfn10-ijerph-06-02934">1</xref></td>
<td valign="middle" align="center">0.181</td><td valign="middle" align="center"/>
<td valign="middle" align="center">0.000</td>
<td valign="middle" align="center">0.574</td>
<td valign="middle" align="center">1596</td></tr>
<tr>
<td valign="middle" align="center" colspan="6"><bold>Low CAC responses (30%)</bold></td></tr>
<tr>
<td valign="middle" align="left"><italic>CAC</italic> × <italic>VE</italic></td>
<td valign="middle" align="center"><italic>0.152</italic></td><td valign="middle" align="center"/>
<td valign="middle" align="center"><bold><italic>0.008</italic></bold></td>
<td valign="middle" align="center"><bold><italic>0.039</italic></bold></td>
<td valign="middle" align="center"><italic>479</italic></td></tr>
<tr>
<td valign="middle" align="left"><italic>sex</italic></td><td valign="middle" align="center"/>
<td valign="middle" align="center"><italic>0.146</italic></td><td valign="middle" align="center"/>
<td valign="middle" align="center"><italic>0.001</italic></td><td valign="middle" align="center"/></tr>
<tr>
<td valign="middle" align="left"><italic>age</italic></td><td valign="middle" align="center"/>
<td valign="middle" align="center"><italic>0.354</italic></td><td valign="middle" align="center"/>
<td valign="middle" align="center"><italic>0.000</italic></td><td valign="middle" align="center"/></tr>
<tr>
<td valign="middle" align="left"><italic>CAC</italic></td><td valign="middle" align="center"/>
<td valign="middle" align="center"><italic>−0.096</italic></td><td valign="middle" align="center"/>
<td valign="middle" align="center"><italic>0.119</italic></td><td valign="middle" align="center"/></tr>
<tr>
<td valign="middle" align="left"><italic>VE</italic></td><td valign="middle" align="center"/>
<td valign="middle" align="center"><italic>0.495</italic></td><td valign="middle" align="center"/>
<td valign="middle" align="center"><italic>0.031</italic></td><td valign="middle" align="center"/></tr>
<tr>
<td valign="middle" align="left"><xref ref-type="table-fn" rid="tfn14-ijerph-06-02934">#</xref>CAC × VE<xref ref-type="table-fn" rid="tfn10-ijerph-06-02934">1</xref></td>
<td valign="middle" align="center">0.212</td><td valign="middle" align="center"/>
<td valign="middle" align="center">0.000</td>
<td valign="middle" align="center">0.423</td>
<td valign="middle" align="center">479</td></tr>
<tr>
<td valign="middle" align="center" colspan="6"><bold>Medium CAC responses (40%)</bold></td></tr>
<tr>
<td valign="middle" align="left">CAC × VE<xref ref-type="table-fn" rid="tfn10-ijerph-06-02934">1</xref></td>
<td valign="middle" align="center">0.107</td><td valign="middle" align="center"/>
<td valign="middle" align="center">0.000</td>
<td valign="middle" align="center">0.799</td>
<td valign="middle" align="center">638</td></tr>
<tr>
<td valign="middle" align="left"><xref ref-type="table-fn" rid="tfn14-ijerph-06-02934">#</xref>CAC × VE<xref ref-type="table-fn" rid="tfn10-ijerph-06-02934">1</xref></td>
<td valign="middle" align="center">0.201</td><td valign="middle" align="center"/>
<td valign="middle" align="center">0.000</td>
<td valign="middle" align="center">0.845</td>
<td valign="middle" align="center">638</td></tr>
<tr>
<td valign="middle" align="center" colspan="6"><bold>High CAC responses (30%)</bold></td></tr>
<tr>
<td valign="middle" align="left">CAC × VE<xref ref-type="table-fn" rid="tfn10-ijerph-06-02934">1</xref></td>
<td valign="middle" align="center">0.150</td><td valign="middle" align="center"/>
<td valign="middle" align="center">0.004</td>
<td valign="middle" align="center">0.117</td>
<td valign="middle" align="center">479</td></tr>
<tr>
<td valign="middle" align="left"><xref ref-type="table-fn" rid="tfn14-ijerph-06-02934">#</xref>CAC × VE<xref ref-type="table-fn" rid="tfn10-ijerph-06-02934">1</xref></td>
<td valign="middle" align="center">0.194</td><td valign="middle" align="center"/>
<td valign="middle" align="center">0.009</td>
<td valign="middle" align="center">0.077</td>
<td valign="middle" align="center">479</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn8-ijerph-06-02934">
<p>VE-vital exhaustion</p></fn><fn id="tfn9-ijerph-06-02934">
<p>CAC-carotid artery compliance (%/10mmHg)</p></fn><fn id="tfn10-ijerph-06-02934">
<label>1</label>
<p>Main effects were included in each analysis but they are presented for low CAC group only</p></fn><fn id="tfn11-ijerph-06-02934">
<label>*</label>
<p>Calculated for the whole model</p></fn><fn id="tfn12-ijerph-06-02934">
<label>**</label>
<p>Refers to main effects</p></fn><fn id="tfn13-ijerph-06-02934">
<label>***</label>
<p>Refers to the interaction term</p></fn><fn id="tfn14-ijerph-06-02934">
<label>#</label>
<p>Additionally adjusted for cardiovascular risk factors: LDL-cholesterol, HDL-cholesterol, triglycerides, insulin, systolic and diastolic blood pressure</p></fn></table-wrap-foot></table-wrap></sec></back></article>
